Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-05-28Clinical Trial Update: A Pharmacokinetic and Relative Bioavailability Study With Rabeprazole Sodium in Healthy Adult Volunteers [Phase 1]
Phase 1 pharmacokinetic and relative bioavailability study of rabeprazole sodium in healthy adult volunteers to characterize its pharmacokin…
-
CLINICAL_TRIALS trial_result · 2014-05-19Clinical Trial Update: TAK-438 - Safety, Blood Levels & Effects of Repeated Doses [Phase 1]
A Phase 1 study evaluating the safety, pharmacokinetics (blood levels), and effects of repeated doses of TAK-438 (vonoprazan) in participant…
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: Research of Efficient Use of Omeprazole in Combination With Domperidone in Gastroesophageal Reflux Disease of Mild to Moderate Severity [Phase 4]
This entry covers a Phase 4 trial evaluating the combination of omeprazole and domperidone for mild-to-moderate gastroesophageal reflux dise…
-
CLINICAL_TRIALS research · 2014-05-16Clinical Trial Update: The Proton Pump Inhibitor (PPI) Test for the Extraesophageal Manifestation of GERD [NA]
This clinical trial update describes an ongoing study at Samsung Medical Center evaluating the Proton Pump Inhibitor (PPI) test for the extr…
-
FDA approval · 2014-05-15FDA Approved: PRILOSEC OTC — Supplemental Application (The Procter & Gamble Manufacturing Company)
FDA approved a supplemental application for Prilosec OTC (omeprazole magnesium) from The Procter & Gamble Manufacturing Company.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: A Study of Local Effect and Safety of a Single PPC-5650 Dose on Reflux Pain During Pain Stimulation in the Esophagus [Phase 1]
A Phase 1 study evaluating the local effect and safety of a single PPC-5650 dose on reflux-related pain in the esophagus has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-01Clinical Trial Update: Esophageal and Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux [Phase 4]
Phase 4 clinical trial completed to evaluate esophageal and laryngeal tissue changes in patients suspected of having laryngopharyngeal reflu…
-
CLINICAL_TRIALS trial_result · 2014-04-28Clinical Trial Update: Study of Changes in Reflux Symptoms and Reflux Finding Score According to Rabeprazole Treatment Period
This completed clinical trial evaluated changes in reflux symptoms and the Reflux Finding Score during different rabeprazole treatment perio…
-
CLINICAL_TRIALS trial_result · 2014-04-28Clinical Trial Update: Practice and Patient Compliance on the PPI (Proton Pump Inhibitors) Treatment of Gastroesophageal Reflux in South Korea
A completed South Korea clinical trial studied practice patterns and patient compliance with proton pump inhibitor therapy for gastroesophag…
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Absolute Bioavailability of YH4808 With Accelerator Mass Spectrometry(AMS)-Based Microdose Study [EARLY_Phase 1]
Early-phase trial reports the absolute bioavailability of YH4808 using AMS-based microdosing in Gastroesophageal Reflux Disease. The study s…
-
CLINICAL_TRIALS trial_result · 2014-04-16Clinical Trial Update: Nexium Capsules Clinical Experience Investigation
Nexium (esomeprazole) capsules completed a clinical experience investigation. The study covered gastric and duodenal ulcers, anastomotic ulc…
-
CLINICAL_TRIALS trial_result · 2014-04-15Clinical Trial Update: Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) [Phase 2]
Phase 2 trial evaluating a selective 5-HT4 receptor agonist with a proton pump inhibitor for GERD has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2014-04-10Clinical Trial Update: Laparoscopic Nissen Versus Anterior Partial Fundoplication [NA]
A completed clinical trial comparing laparoscopic Nissen fundoplication versus anterior partial fundoplication for gastroesophageal reflux d…
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: Inter-rater Reliability of the Reflux Finding Score Among Gastroenterologists
This clinical trial assesses inter-rater reliability of the Reflux Finding Score among gastroenterologists evaluating patients with laryngit…
-
CLINICAL_TRIALS research · 2014-04-07Clinical Trial Update: Assessment of GERD Knowledge Level Among Patients With it in Korea
A clinical trial update assessing GERD knowledge levels among Korean patients with esophagitis or reflux. The study is sponsored by Chuncheo…
-
CLINICAL_TRIALS trial_result · 2014-04-04Clinical Trial Update: Gastroesophageal Reflux Disease (GERD) Before and After Gastric Bypass
Completed clinical trial evaluating gastroesophageal reflux disease before and after gastric bypass has posted results.
-
CLINICAL_TRIALS research · 2014-03-31Clinical Trial Update: Anthropometry in Gastroesophageal Reflux Disease and Esophageal Injury [NA]
This entry reports a completed Mayo Clinic study examining anthropometric measurements in patients with gastroesophageal reflux disease. The…
-
FDA approval · 2014-02-25FDA Approved: PRILOSEC — Supplemental Application (Covis Pharma US, Inc)
FDA approved a supplemental application for Prilosec (omeprazole magnesium) from Covis Pharma US, Inc. The approval updates the labeling for…
-
CLINICAL_TRIALS trial_result · 2014-02-25Clinical Trial Update: Omeprazole and Reflux Disease - Improvement of Clinical Outcome by Genotype-adjusted Dosing [Phase 4]
Phase 4 clinical trial evaluating genotype-adjusted dosing of omeprazole for gastroesophageal reflux disease, reporting improvement in clini…
-
FDA label_change · 2014-02-25FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Nexium (esomeprazole magnesium) submitted by AstraZeneca, resulting in changes to the product la…
-
FDA approval · 2014-02-14FDA Approved: OMEPRAZOLE MAGNESIUM — Supplemental Application (Gericare Pharmaceuticals)
FDA approved a supplemental application for Omeprazole Magnesium by Gericare Pharmaceuticals, updating the approval status for this generic …
-
CLINICAL_TRIALS trial_result · 2014-02-12Clinical Trial Update: Feasibility Study for Evaluating the Effect of Electrical Stimulation on Lower Esophageal Sphincter Pressure and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease [Phase 2]
Phase 2 feasibility study evaluating electrical stimulation of the lower esophageal sphincter to influence LES pressure and esophageal acid …
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: Resolving Bile Reflux by Lanreotide in Patients With Roux-en-Y Gastrojejunostomy [Phase 2]
Phase 2 clinical trial evaluating lanreotide to resolve bile reflux in patients with Roux-en-Y gastrojejunostomy. The trial status is curren…
-
FDA approval · 2014-01-29FDA Approved: METOCLOPRAMIDE HYDROCHLORIDE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
FDA approved a supplemental application for metoclopramide hydrochloride from Chartwell Governmental & Specialty RX, LLC., indicating approv…
-
CLINICAL_TRIALS trial_result · 2014-01-15Clinical Trial Update: Medical Treatment for Gastroesophageal Reflux Disease (GERD) in Preterm Infants [Phase 3]
Phase 3 clinical trial evaluating medical treatment for gastroesophageal reflux disease in preterm infants has completed and results have be…